biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a1in-01a-11d-a13l-09
biospecimen_aliquot__bcr_aliquot_uuid	9e85559f-098e-4b0f-8034-4798789e710b
biospecimen_aliquot__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a1in-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108474687
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-03-23
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	9
biospecimen_aliquot__plate_id	a13l
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	1.75
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a1in-01a-11d
biospecimen_analyte__bcr_analyte_uuid	d7ddb81e-74db-4ef3-9c11-0d0f416c041e
biospecimen_analyte__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a1in-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a1in
biospecimen_diagnostic_slides__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a1in-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	f63f004f-847d-41b0-baef-3189d4965838
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a1in
biospecimen_normal_control__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
biospecimen_normal_control__ncedna_dna_conc	0.380
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	53
biospecimen_normal_control__normal_tissue_anatomic_site	other
biospecimen_portion__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
biospecimen_portion__bcr_portion_barcode	tcga-e2-a1in-01a-11
biospecimen_portion__bcr_portion_uuid	4d187272-4759-4f09-8dfe-dc860309c109
biospecimen_portion__bcr_sample_barcode	tcga-e2-a1in-01a
biospecimen_portion__date_of_creation	2011-02-23
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	10.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a1in-01a-11d
biospecimen_protocol__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a1in-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
biospecimen_sample__bcr_sample_barcode	tcga-e2-a1in-01a
biospecimen_sample__bcr_sample_uuid	24153fe0-2c47-456a-b344-874a0e28de4d
biospecimen_sample__days_to_collection	368
biospecimen_sample__initial_weight	20
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a1in.cc0b1145-b242-45bd-a946-b14ba5a9e923.pdf
biospecimen_sample__pathology_report_uuid	cc0b1145-b242-45bd-a946-b14ba5a9e923
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
biospecimen_slide__bcr_sample_barcode	tcga-e2-a1in-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a1in-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	d8b99a48-e9a4-4bc0-8ecd-0eecf195803e
biospecimen_slide__image_file_name	tcga-e2-a1in-01a-01-tsa.d8b99a48-e9a4-4bc0-8ecd-0eecf195803e.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	1
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	4
biospecimen_slide__percent_tumor_cells	95
biospecimen_slide__percent_tumor_nuclei	85
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a1in
biospecimen_tumor_sample__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
clinical_drug__bcr_drug_barcode	tcga-e2-a1in-d20324
clinical_drug__bcr_drug_uuid	f7685815-0bf1-443b-9f43-01b6887e6a92
clinical_drug__bcr_patient_barcode	tcga-e2-a1in
clinical_drug__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
clinical_drug__form_completion_date	2012-1-4
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	103
clinical_drug__pharmaceutical_tx_total_dose_units	mg/day
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	1
clinical_follow_up__bcr_followup_barcode	tcga-e2-a1in-f20323
clinical_follow_up__bcr_followup_uuid	14834e52-b0e0-43d7-b13b-32a3d0d390e3
clinical_follow_up__bcr_patient_barcode	tcga-e2-a1in
clinical_follow_up__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-1-4
clinical_follow_up__last_contact_days_to	675
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	60
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage i
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	right
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-e2-a1in
clinical_patient__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
clinical_patient__birth_days_to	-22199
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 5+3=8
clinical_patient__er_positivity_scale_other	allred score = 8
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-4-29
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	392
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	2
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a1in
clinical_patient__pr_positivity_define_method	allred score 5+3+8
clinical_patient__pr_positivity_scale_other	allred score = 8
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a1in
clinical_radiation__bcr_patient_uuid	f43d622f-eed5-4933-adc6-ae9ad1e33028
clinical_radiation__bcr_radiation_barcode	tcga-e2-a1in-r20326
clinical_radiation__bcr_radiation_uuid	ef81f606-fafb-46f1-82db-b3285d7a9803
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2012-1-4
clinical_radiation__radiation_adjuvant_fractions_total	33
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	101
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	57
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6040
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1IN-01A-11D-A13L-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1IN-01A-11D-A13L-09.bed.meta
manually_curated__id	tcga-e2-a1in-01a-11d-a13l-09
manually_curated__md5sum	a29e0316717cd14ec8c659e43cc5517a
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	9e85559f-098e-4b0f-8034-4798789e710b
manually_curated__tumor_tag	brca
